These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 17544960)

  • 21. [Solitary morphea profunda: An unusual form of localized scleroderma in childhood. Case report].
    de la Fuente-Laso P; González-García J; Castaño-Rivero A; Gonzalvo-Rodríguez P; Rodríguez-Díaz E; Vázquez-Osorio I
    Arch Argent Pediatr; 2019 Apr; 117(2):e137-e141. PubMed ID: 30869492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fasciitis eosinophilica--transition to an unusual scleroderma (scleroderma-fasciitis)].
    Jablonska S; Hamm G; Kencka D; Sieminska S
    Z Hautkr; 1984 Jun; 59(11):711-21. PubMed ID: 6485447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphea profunda presenting as a neuromuscular mimic.
    Voermans NC; Pillen S; de Jong EM; Creemers MC; Lammens M; van Alfen N
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):407-14. PubMed ID: 18525425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric morphea.
    Browning JC
    Dermatol Clin; 2013 Apr; 31(2):229-37. PubMed ID: 23557652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic and immunophenotypic features of eosinophilic fasciitis and morphea profunda: A comparative study of 27 cases.
    Onajin O; Wieland CN; Peters MS; Lohse CM; Lehman JS
    J Am Acad Dermatol; 2018 Jan; 78(1):121-128. PubMed ID: 28865864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [AWMF Guideline no. 013/066. Diagnosis and therapy of circumscribed scleroderma].
    Kreuter A; Krieg T; Worm M; Wenzel J; Gambichler T; Kuhn A; Aberer E; Scharffetter-Kochanek K; Hunzelmann N;
    J Dtsch Dermatol Ges; 2009 Sep; 7 Suppl 6():S1-14. PubMed ID: 19660073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasonography as an auxiliary diagnostic tool for morphea profunda: A case report.
    Hsieh M; Tokoro S; Ugajin T; Namiki T; Miura K; Yokozeki H
    J Dermatol; 2019 Jul; 46(7):626-630. PubMed ID: 31149739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eosinophilic fascitis (Shulman syndrome) in a 13-year-old girl.
    Clemmensen OJ; Thomsen K
    Acta Derm Venereol; 1980; 60(3):271-4. PubMed ID: 6158236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eosinophilic fasciitis/generalized morphea overlap.
    Heidary N; Cheung W; Wang N; Kamino H; Franks AG
    Dermatol Online J; 2009 Aug; 15(8):2. PubMed ID: 19891910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrophoderma Pasini-Pierini is a primary atrophic abortive morphea.
    Kencka D; Blaszczyk M; Jabłońska S
    Dermatology; 1995; 190(3):203-6. PubMed ID: 7599381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localized cutaneous scleroderma.
    Krafchik BR
    Semin Dermatol; 1992 Mar; 11(1):65-72. PubMed ID: 1550717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis.
    Falanga V; Medsger TA
    J Am Acad Dermatol; 1987 Oct; 17(4):648-56. PubMed ID: 3668010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory morphea in the context of Raynaud phenomenon.
    Abbasi N; Firoz B; Bossenbroek NM; Meehan SA; Kamino H; Franks AG
    Dermatol Online J; 2008 Oct; 14(10):11. PubMed ID: 19061610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New developments in localized scleroderma.
    Zulian F
    Curr Opin Rheumatol; 2008 Sep; 20(5):601-7. PubMed ID: 18698185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
    Soh HJ; Samuel C; Heaton V; Renton WD; Cox A; Munro J
    Rheumatol Int; 2019 May; 39(5):933-941. PubMed ID: 30838436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinical picture of morphea].
    Wojas-Pelc A; Wielowieyska-Szybińska D
    Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort.
    Kim A; Marinkovich N; Vasquez R; Jacobe HT
    J Rheumatol; 2014 Jan; 41(1):106-12. PubMed ID: 24293577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Linear circumscribed scleroderma--case report. Classification and differentiation of circumscribed scleroderma].
    Senff H; Mensing H; Jänner M; Kuhlwein A
    Z Hautkr; 1988 Mar; 63(3):221-4. PubMed ID: 3388926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Juvenile case of multiple morphea profunda resulting in joint contracture that was successfully treated with cyclosporin A: A case report and review of the published works.
    Ogawa T; Okiyama N; Takamuki R; Inoue S; Saito A; Nakamura Y; Ishitsuka Y; Watanabe R; Fujisawa Y; Fujimoto M
    J Dermatol; 2019 Apr; 46(4):354-357. PubMed ID: 30701571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localized forms of scleroderma, including morphea, linear scleroderma, and eosinophilic fasciitis.
    Nelson AM
    Curr Opin Rheumatol; 1996 Sep; 8(5):473-6. PubMed ID: 8941452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.